Literature DB >> 17617474

Opioid receptor blockade increases the number of lymphocytes without altering T cell response in draining lymph nodes in vivo.

Martial Jaume1, Sophie Laffont, Emmanuelle Chapey, Catherine Blanpied, Gilles Dietrich.   

Abstract

A number of studies have been dedicated to estimate the consequences on immunity of the clinical use of opioids by focusing on mitogen-induced polyclonal proliferation of T cells from blood or spleen. Here we examined, under physiological conditions, the contribution of endogenous opioids in the development of a CD4(+) T cell response within draining lymph nodes. We show in OVA-primed DO11.10 mice that delta-opioid receptors were up-regulated upon T cell activation in vivo and that opioid receptor neutralization increased the number of specific anti-OVA T lymphocytes without promoting their capacity to proliferate. The sensitivity to Fas-mediated apoptosis of T lymphocytes and the synthesis of homeostatic lymphoid chemokines were not either affected suggesting that opioids operate mainly before the entry of T lymphocytes into lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617474     DOI: 10.1016/j.jneuroim.2007.06.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Protease-activated receptors as therapeutic targets in visceral pain.

Authors:  Nicolas Cenac
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

2.  Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.

Authors:  Parvathi Ranganathan; Hao Chen; Miranda K Adelman; Samuel F Schluter
Journal:  J Neuroimmunol       Date:  2009-10-30       Impact factor: 3.478

3.  T-lymphocyte-derived enkephalins reduce Th1/Th17 colitis and associated pain in mice.

Authors:  Lilian Basso; Laure Garnier; Arnaud Bessac; Jérôme Boué; Catherine Blanpied; Nicolas Cenac; Sophie Laffont; Gilles Dietrich
Journal:  J Gastroenterol       Date:  2017-04-19       Impact factor: 7.527

4.  Morphine induces splenocyte trafficking into the CNS.

Authors:  Michael Olin; Seunguk Oh; Sabita Roy; Phillip Peterson; Thomas Molitor
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-20       Impact factor: 4.147

5.  Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.

Authors:  Patricia J McLaughlin; Daniel P McHugh; Marcus J Magister; Ian S Zagon
Journal:  BMC Immunol       Date:  2015-04-24       Impact factor: 3.615

6.  Endogenous analgesia mediated by CD4(+) T lymphocytes is dependent on enkephalins in mice.

Authors:  Lilian Basso; Jérôme Boué; Karim Mahiddine; Catherine Blanpied; Sébastien Robiou-du-Pont; Nathalie Vergnolle; Céline Deraison; Gilles Dietrich
Journal:  J Neuroinflammation       Date:  2016-06-01       Impact factor: 8.322

7.  Pain Management in a Model of Interstitial Cystitis/Bladder Pain Syndrome by a Vaccinal Strategy.

Authors:  Céline Augé; Lilian Basso; Catherine Blanpied; Nathalie Vergnolle; Xavier Gamé; Sophie Chabot; Philippe Lluel; Gilles Dietrich
Journal:  Front Pain Res (Lausanne)       Date:  2021-03-08

8.  Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cells.

Authors:  Céline Kerros; Thibault Cavey; Brigitte Sola; Philippe Jauzac; Stéphane Allouche
Journal:  J Exp Clin Cancer Res       Date:  2009-06-07

Review 9.  Opioid Receptors in Immune and Glial Cells-Implications for Pain Control.

Authors:  Halina Machelska; Melih Ö Celik
Journal:  Front Immunol       Date:  2020-03-04       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.